# Phase 1 infections trials recruiting: 72 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 72 trials in phase 1 for infections that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 infections trials: 72 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/infections

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 72
- Recruiting or not yet: 72
- Read on: November 19, 2026

## Trials

The 25 newest of 72, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07942779 | AVL-102 for the Treatment of HPV 16/18/52/58-Related High-Grade Lesions | Beijing Xunsheng Biomedical Research Co., Ltd. | Phase 1 | Recruiting | CIN 2/3, HPV Infections | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942779) |
| November 16, 2026 | NCT07939594 | An Evaluation of the Potential for VH4011499 Drug-drug-interactions | ViiV Healthcare | Phase 1 | Not yet recruiting | HIV Infections | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939594) |
| November 13, 2026 | NCT07934719 | Mass Balance and Absolute Bioavailability of \[14C\]-VH4011499 | ViiV Healthcare | Phase 1 | Not yet recruiting | HIV Infections | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934719) |
| October 29, 2026 | NCT07902583 | Pancoronavirus Vaccine Study in Healthy Adults Ages 18-55 | Duke University | Phase 1 | Not yet recruiting | Coronavirus Infection | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902583) |
| October 22, 2026 | NCT07888088 | Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults | Bavarian Nordic | Phase 1 | Not yet recruiting | Epstein Barr Virus (EBV) Infection | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888088) |
| September 16, 2026 | NCT07822477 | A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV | ViiV Healthcare | Phase 1 | Not yet recruiting | HIV Infections | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822477) |
| September 14, 2026 | NCT07818915 | A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants | ViiV Healthcare | Phase 1 | Recruiting | HIV Infections | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818915) |
| September 14, 2026 | NCT07818629 | A Study to Evaluate INT101 in Healthy Adults for the Prevention of Norovirus Gastroenteritis | InThera Inc. Korea | Phase 1 | Recruiting | Norovirus Infections, Norovirus Gastroenteritis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818629) |
| July 16, 2026 | NCT07708116 | First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients | Centauri Therapeutics Limited | Phase 1 | Recruiting | Bronchiectasis Adult, Bronchiectasis With Pseudomonas Aeruginosa Colonization, Bacterial Infections | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07708116) |
| July 14, 2026 | NCT07703475 | A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | COVID -19 | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07703475) |
| June 23, 2026 | NCT07663032 | A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent... | GlaxoSmithKline | Phase 1 | Recruiting | Salmonella Infections | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663032) |
| June 16, 2026 | NCT07649096 | A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Recruiting | Clostridium Difficile Infection | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07649096) |
| June 12, 2026 | NCT07645235 | A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women | GlaxoSmithKline | Phase 1 | Recruiting | Urinary Tract Infections | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645235) |
| June 9, 2026 | NCT07636928 | Mass Balance and Absolute Oral Bioavailability of \[14C\]VH4524184 | ViiV Healthcare | Phase 1 | Recruiting | HIV Infections | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636928) |
| June 1, 2026 | NCT07616934 | A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults | Vaxcyte, Inc. | Phase 1 | Recruiting | Group A Streptococcal Infection | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616934) |
| May 29, 2026 | NCT07614282 | Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | PTLD, Epstein Barr Virus (EBV) Infection, Solid Organ Transplant | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614282) |
| May 4, 2026 | NCT07565090 | A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV... | International AIDS Vaccine Initiative | Phase 1 | Recruiting | Sudan Virus Disease | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565090) |
| April 29, 2026 | NCT07557602 | mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults | Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company | Phase 1 | Recruiting | EBV | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07557602) |
| April 22, 2026 | NCT07544589 | A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers | Dispatch Biotherapeutics | Phase 1 | Recruiting | Colorectal Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Biliary Tract... | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07544589) |
| April 13, 2026 | NCT07525544 | A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants | ViiV Healthcare | Phase 1 | Recruiting | HIV Infections | 214 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07525544) |
| April 3, 2026 | NCT07510282 | Probiotic Delivered to the Small Intestine Changes Microbiota | University College Dublin | Phase 1 | Not yet recruiting | Colonization, Asymptomatic, Colonization | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07510282) |
| March 25, 2026 | NCT07492771 | MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia | MicrobiotiX Co., Ltd | Phase 1 | Recruiting | Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492771) |
| March 18, 2026 | NCT07478952 | A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age | ModernaTX, Inc. | Phase 1 | Recruiting | Epstein-Barr Virus | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07478952) |
| February 27, 2026 | NCT07439978 | Encapsulated Probiotics & Gut Microbiota | University College Dublin | Phase 1 | Not yet recruiting | Colonization, Asymptomatic, Colonisation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07439978) |
| February 10, 2026 | NCT07401680 | Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population | University of Alberta | Phase 1 | Recruiting | Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401680) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [ViiV Healthcare](https://specstream.ai/data/clinical-trials/company/viiv-healthcare) | 9 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 8 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 4 |
| Baylor College of Medicine | 3 |
| University College Dublin | 2 |
| National Cancer Institute (NCI) | 2 |
| Chinese PLA General Hospital | 2 |
| [Sinovac Life Sciences Co., Ltd.](https://specstream.ai/data/clinical-trials/company/sinovac-life-sciences-co-ltd) | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| [Bavarian Nordic](https://specstream.ai/data/clinical-trials/company/bavarian-nordic) | 1 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company | 1 |
| InThera Inc. Korea | 1 |
| [Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd](https://specstream.ai/data/clinical-trials/company/beijing-zhifei-lvzhu-biopharmaceutical-co-ltd) | 1 |
| Beijing Xunsheng Biomedical Research Co., Ltd. | 1 |
| Duke University | 1 |
| Arrowhead Regional Medical Center | 1 |
| AIDS Malignancy Consortium | 1 |
| BlueSky Immunotherapies GmbH | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| International AIDS Vaccine Initiative | 1 |
| [CanSino Biologics Inc.](https://specstream.ai/data/clinical-trials/company/cansino-biologics-inc) | 1 |
| Brigham and Women's Hospital | 1 |
| Centauri Therapeutics Limited | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 36 |
| China | 10 |
| Australia | 7 |
| South Korea | 2 |
| Netherlands | 2 |
| South Africa | 2 |
| Thailand | 1 |
| Slovakia | 1 |
| Peru | 1 |
| Canada | 1 |
| Germany | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tiki bars in the United States](https://specstream.ai/data/businesses/tiki-bars/united-states)
- [Wholesale florists in the United States](https://specstream.ai/data/businesses/wholesale-florists/united-states)
- [Automation companies in the United States](https://specstream.ai/data/businesses/automation-companies/united-states)
- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [Cigar bars in the United States](https://specstream.ai/data/businesses/cigar-bars/united-states)
- [Distilleries in the United States](https://specstream.ai/data/businesses/distilleries/united-states)
